United Therapeutics Corpo... (UTHR)

NASDAQ: UTHR · Real-Time Price · USD

293.57

-9.52 (-3.14%)

At close: May 01, 2025, 3:59 PM

299.99

2.19%

After-hours: May 01, 2025, 05:44 PM EDT

United Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	1.7B	1.21B	961.2M	894.8M	738.7M	738.4M	669.2M	705.1M	1.02B
Short-Term Investments	1.57B	1.79B	1.88B	1.04B	1.1B	747.5M	746.7M	222.3M	27.8M
Long-Term Investments	1.48B	1.91B	1.32B	1.65B	1.15B	767.5M	442.6M	502.7M	2.3M
Other Long-Term Assets	222.1M	151.8M	114.3M	108.2M	169.9M	154.6M	224.2M	224.1M	197.1M
Receivables	279.3M	278.9M	220.4M	198.7M	157.4M	151.4M	175.7M	297.1M	214.5M
Inventory	157.9M	111.8M	102M	93.8M	86.5M	93.4M	101M	107.9M	100M
Other Current Assets	169.7M	166.2M	219.2M	100.4M	88.3M	133.8M	75.4M	115.5M	59.5M
Total Current Assets	3.87B	3.55B	3.38B	2.32B	2.17B	1.86B	1.77B	1.45B	1.42B
Property-Plant & Equipment	1.22B	1.05B	861.5M	780.9M	731.6M	738.5M	699.7M	545.7M	489.3M
Goodwill & Intangibles	111.9M	114.2M	44.5M	44.6M	158.1M	158.3M	170.8M	45.6M	33.8M
Total Long-Term Assets	3.49B	3.62B	2.66B	2.85B	2.45B	2.05B	1.63B	1.43B	900.8M
Total Assets	7.36B	7.17B	6.04B	5.17B	4.62B	3.91B	3.4B	2.88B	2.33B
Account Payables	6M	5.6M	4.1M	3.8M	4.1M	9.9M	23.1M	8.4M	8.1M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	163.5M	n/a	n/a	n/a
Short-Term Debt	n/a	400M	n/a	n/a	n/a	250M	n/a	n/a	n/a
Other Current Liabilities	732.1M	40.5M	13M	248M	20.4M	22.1M	215.6M	401.7M	293.8M
Total Current Liabilities	738.1M	804.4M	343.2M	305.4M	323.3M	463M	276.6M	444.7M	332.5M
Long-Term Debt	n/a	300M	800M	800M	800M	600M	250M	250M	n/a
Other Long-Term Liabilities	181.9M	77.8M	104.6M	104.8M	96.5M	70M	66.6M	63.7M	130.9M
Total Long-Term Liabilities	181.9M	377.8M	904.6M	904.8M	896.5M	670M	316.6M	313.7M	130.9M
Total Liabilities	920M	1.18B	1.25B	1.21B	1.22B	1.13B	612.4M	777.6M	463.4M
Total Debt	300M	700M	800M	800M	800M	850M	250M	250M	n/a
Common Stock	800K	700K	700K	700K	700K	700K	700K	700K	700K
Retained Earnings	7.22B	6.03B	5.04B	4.32B	3.84B	3.33B	3.43B	2.85B	2.43B
Comprehensive Income	-3.4M	-12.8M	-55.5M	-23M	-14.2M	-14.2M	-7.9M	-19.6M	-16.8M
Shareholders Equity	6.44B	5.98B	4.8B	3.96B	3.4B	2.78B	2.79B	2.1B	1.86B
Total Investments	3.05B	3.7B	3.19B	2.69B	2.25B	1.51B	1.19B	725M	30.1M